The I-MOVE (Influenza – Monitoring Vaccine Effectiveness in Europe) network aims to measure influenza vaccine effectiveness (VE) in Europe. The I-MOVE network includes a multicentre study at primary care level to measure influenza VE and a multicentre study carried out at hospital level to measure VE against severe influenza. Within the I-MOVE network we also carry out studies measuring the impact of influenza vaccination campaigns.
The project started in 2007 and has carried out multicentre and other studies since the 2008–9 influenza season. The network consists of 29 partners including ECDC, WHO-EURO, regional and national public health institutes, hospitals, small and medium enterprises, and universities from 15 European Union/European Economic Area Member States. The I-MOVE network measures VE in a way that is scientifically and financially independent from vaccine manufacturers.
Development of generic protocols to measure influenza vaccine effectiveness studies
test-negative design, cohort, screening method, impact studies.
Coordination of multicentre, multicountry surveillance and research networks
review of protocols, organisation of scientific conferences and technical workshops, training
Pooled analysis to provide vaccine effectiveness at European level
data management, data validation, development of scripts, report writing, scientific communication